Sumitomo Mitsui DS Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,343
| Closed | -$202K | – | 764 |
|
|
2025
Q1 | $202K | Sell |
1,343
-4,608
| -77% | -$694K | ﹤0.01% | 751 |
|
|
2024
Q4 | $1.1M | Buy |
5,951
+133
| +2% | +$24.6K | 0.01% | 612 |
|
|
2024
Q3 | $1.15M | Buy |
5,818
+141
| +2% | +$27.8K | 0.01% | 603 |
|
|
2024
Q2 | $1.17M | Buy |
5,677
+1,386
| +32% | +$286K | 0.01% | 574 |
|
|
2024
Q1 | $1.16M | Buy |
4,291
+46
| +1% | +$12.5K | 0.01% | 566 |
|
|
2023
Q4 | $1M | Hold |
4,245
| – | – | 0.01% | 610 |
|
|
2023
Q3 | $832K | Buy |
4,245
+79
| +2% | +$15.5K | 0.01% | 599 |
|
|
2023
Q2 | $876K | Buy |
4,166
+26
| +0.6% | +$5.47K | 0.01% | 591 |
|
|
2023
Q1 | $836K | Buy |
4,140
+50
| +1% | +$10.1K | 0.02% | 584 |
|
|
2022
Q4 | $891K | Buy |
4,090
+48
| +1% | +$10.5K | 0.02% | 545 |
|
|
2022
Q3 | $795K | Buy |
4,042
+921
| +30% | +$181K | 0.02% | 545 |
|
|
2022
Q2 | $668K | Buy |
3,121
+50
| +2% | +$10.7K | 0.02% | 578 |
|
|
2022
Q1 | $872K | Sell |
3,071
-461
| -13% | -$131K | 0.02% | 551 |
|
|
2021
Q4 | $1.33M | Buy |
3,532
+465
| +15% | +$175K | 0.03% | 458 |
|
|
2021
Q3 | $1.27M | Sell |
3,067
-20
| -0.6% | -$8.25K | 0.03% | 443 |
|
|
2021
Q2 | $1.14M | Buy |
+3,087
| New | +$1.14M | 0.03% | 469 |
|